Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories

Series B

Alentis accesses $67m series B
Morningside Venture Investments has led a series B round for the fibrotic diseases-focused spinout that advances University of Strasbourg research.
Daily deal net: June 14, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Lilly helps inject $108m into Synthekine
The immuno-oncology therapy developer has amassed at least $190m of overall funding since emerging out of Stanford University.
Aiforia visualises $15.4m series B
Helsinki spinout Aiforia has raised an initial $15.4m in series B funding, bringing it halfway to the round’s target.
QitanTech keeps pace through $63m series B
The Tsinghua-backed DNA and RNA sequencing equipment manufacturer has added $63m to its coffers.
LeoLabs makes space for $65m series B
The low Earth orbit mapping technology provider has raised more than $100m altogether, having picked up series A financing from Weru Investment in 2018.
AWL advances to $18.2m round
Hokkaido spinout AWL has collected fresh funding from a consortium led by Rakuten Capital.
ANU helps pour $13.7m into Liquid Instruments
ANU Connect Ventures has participated in a series B round for Liquid Instruments, which builds on research at Australian National University.

Other News

Twaice twinkles with $26m series B
The battery optimisation software spinout of TUM has received the new funding after a UVC Partners-backed series A round closed approximately a year ago.
Zap Energy powers up series B
Based on research at University of Washington and Lawrence Livermore National Laboratory, Zap Energy is working on a nuclear fusion reactor.
ThinkCyte contemplates $26m in funding
Sparx has returned to lead the OUVC-backed cell-based therapeutic technology developer’s series B round, which brought its overall funding to almost $45m.
UltraSight sees through $13m series B
Weizmann Institute of Science participated in a series B round for its spinout that was originally known as OnSight Medical.
Startbahn coins $10.5m series B
Kyoto University and University of Tokyo both participated in a series B round for the artwork-focused blockchain technology developer.
Lightmatter illuminates $80m series B
The photonic computing technology spinout of MIT has now pocketed $113m in funding altogether.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Canvas paints $9m picture
Canvas Network, an online education platform developed by learning management software (LMS) provider Instructure which received $9.1m investment for the platform, has begun offering free and open online courses.
WRF finds its Resolve
In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
Imperial helps PsiOxus raise $34m
UK-listed investment fund Imperial Innovations joins GlaxoSmithKline's SR One, fund manager Invesco Perpetual and Lundbeckfond Ventures, backing the d cancer treatment company.
test reg